We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia (HDL)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01569659
First Posted: April 3, 2012
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Sunovion
Information provided by (Responsible Party):
Herbert Meltzer, Northwestern University
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)